Search results
PROMOTED
Rhythm Interventions Online is back! Mark your calendars for Thursday 20 and Friday 21 November, as we bring you the most dynamic and immersive virtual experience in electrophysiology and cardiac rhythm management.
After five hugely successful editions, RIO has cemented its place as a must-attend global event, delivering world-class education to thousands of healthcare professionals worldwide.
…
View more
RIO 2025 - Day One | Global
Start date:
Nov 20, 2025
Broadcast
The Global Impact of AF
Added:
1 week ago
Article
Added:
6 days ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then…
View more
Added:
8 months ago
What updates do ECAS recommend for catheter ablation of atrial fibrillation?In this short interview, Prof Riccardo Cappato (IRCCS Humanitas Research Hospital, Milan, IT) and Prof Rui Providência (St Bartholomew's Hospital, London, UK) discuss new guidelines released by ECAS on catheter ablation for atrial fibrillation (AF). Prof Cappato and Prof Providência explain the need for an updated and…
View more
Added:
1 year ago
AF Symposium 2024 – In this interview, Dr Christopher R Ellis (Vanderbilt University Medical Center, US) joins us to discuss the early findings from the EMERGE LAA Post-Approval Study.The study investigated the early postapproval outcomes of the Amulet occluder device within the United States, using data from the Left Atrial Appendage Occlusion Registry.Questions:What is the background of this…
View more
Added:
1 year ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more
Added:
1 year ago
ESC Congress 2024 — OCEANIC-AF was halted early due to a lack of efficacy in 2023. Investigators shared details of the trial at ESC, comparing asundexian against apixaban in patients with atrial fibrillation at risk of stroke.Host Dr Harriette Van Spall (McMaster University, Hamilton, Canada) sits down with primary investigator Dr Manesh R Patel (Duke University Health System, USA) to discuss the…
View more
NHAF 2025
Start date:
Nov 13, 2025
End date:
Nov 13, 2025
Event
Added:
2 years ago
Dr Else Sandset (Oslo University Hospital, NO) is joined by Prof Jesse Dawson (University of Glasgow, GB), Dr Urs Fischer (University Hospital Basel, CH) and Dr Masatoshi Koga (National Cerebral and Cardiovascular Center, JP) to discuss the findings from their recent paper on "Early versus Later Anticoagulation for Stroke with Atrial Fibrillation" published in the New England Journal of Medicine…
View more
Added:
1 year ago
HRS 2024 — Prof Isabel Deisenhofer (German Heart Center Munich, Technical University of Munich, DE), investigator, joins us to discuss the findings from the TAILORED-AF trial (NCT04702451, Volta Medical).This randomised controlled trial compared a tailored ablation strategy targeting areas of patio-temporal dispersion in combination with pulmonary vein isolation (PVI) to anatomical ablation…
View more